Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient
US-9463175-B2 · Oct 11, 2016 · US
This page is not indexed by search engines while we improve data quality.
Sbi Pharmaceuticals Co Ltd — Cross-Sectional Technologies
Sbi Pharmaceuticals Co Ltd holds 4 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Sbi Pharmaceuticals Co Ltd |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 4 |
| Recent patents in slice | 0 |
| First year | 2015 |
| Last year | 2016 |
Representative patents
Notable publications linking Sbi Pharmaceuticals Co Ltd to Cross-Sectional Technologies.
Antimalarial drug comprising alaremycin or derivative thereof as active ingredient
US-9295660-B2 · Mar 29, 2016 · US
Antimalarial Drug Which Contains 5-Aminolevulinic Acid or Derivative Thereof as Active Ingredient
US-2015283102-A1 · Oct 8, 2015 · US
Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient
US-9089530-B2 · Jul 28, 2015 · US
Recent filings
Latest patents from Sbi Pharmaceuticals Co Ltd in Cross-Sectional Technologies.
Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient
US-9463175-B2 · Oct 11, 2016 · US
Antimalarial drug comprising alaremycin or derivative thereof as active ingredient
US-9295660-B2 · Mar 29, 2016 · US
Antimalarial Drug Which Contains 5-Aminolevulinic Acid or Derivative Thereof as Active Ingredient
US-2015283102-A1 · Oct 8, 2015 · US
Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient
US-9089530-B2 · Jul 28, 2015 · US
Related pages
Navigate to parent entity pages.